Next-generation tourniquets market seen reaching $270 million by 2030

The global next-generation tourniquets market is projected to grow from $190 million in 2025 to $270 million by 2030, driven by trauma care demand, military modernization and emergency response adoption. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Next-generation tourniquets are used to stop life-threatening bleeding fast in combat, emergency and prehospital settings. - The market’s growth reflects wider demand for better hemorrhage control tools as trauma cases rise and emergency systems expand. - The report also points to broader adoption in civilian response settings, which could widen the market beyond military use.

What happened: - The Business Research Company published its Next-Generation Tourniquets Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the market will rise from $0.19 billion in 2025 to $0.21 billion in 2026. - It forecasts the market will reach $0.27 billion by 2030, implying a 7.2% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - Next-generation tourniquets use mechanical systems such as windlass devices, ratchets or electronic pressure sensors to stop arterial bleeding in limbs. - The devices are designed for rapid one-handed application. - The report says the devices aim to reduce blood loss while limiting nerve and tissue damage through more precise pressure distribution. - Historic growth from 2025 to 2026 was supported by military modernization, more traumatic injuries, stronger emergency medical services infrastructure, higher awareness of hemorrhage control and broader use of prehospital trauma care equipment. - Forecast growth is tied to smart pressure monitoring, more funding for tactical medical gear, disaster preparedness, civilian emergency response adoption and demand for minimally invasive hemorrhage control devices. - Key trends include wider use of one-handed rapid-application tourniquets, lighter and more ergonomic designs, civilian bleeding-control initiatives, better junctional hemorrhage management tools and standardization of tactical combat casualty care protocols. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - Traumatic injuries are a core demand driver because severe bleeding often requires immediate control before patients reach advanced care. - The report cites CDC data showing 68,663 traumatic brain injury-related deaths in the U.S. in 2023 and about 214,110 related hospitalizations. - The report also cites OECD data showing U.S. preventable mortality at 217 deaths per 100,000 population in November 2025, above the OECD average of 145. - Those figures underscore the broader pressure on trauma systems and the market for faster bleeding-control tools.

What's next: - The market is expected to keep expanding through 2030 as smart monitoring and tactical medical gear improve. - Civilian adoption and disaster preparedness spending could become more important growth drivers. - Asia-Pacific may narrow the gap with North America if forecast growth materializes.

The bottom line: - Next-generation tourniquets are moving from niche tactical gear toward a broader trauma-care market, and the report sees steady growth through the end of the decade.